Search

Your search keyword '"Arzu Yorgancioglu"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Arzu Yorgancioglu" Remove constraint Author: "Arzu Yorgancioglu" Topic asthma Remove constraint Topic: asthma
66 results on '"Arzu Yorgancioglu"'

Search Results

1. Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®

2. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study

3. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach

4. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD

5. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

6. Asthma Control Test and Asthma Quality of Life Questionnaire Association in Adults

7. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

8. Development and validation of combined symptom-medication scores for allergic rhinitis*

9. Management of anaphylaxis due to COVID-19 vaccines in the elderly

10. Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement

11. Cutoff Values of MASK-air Patient-Reported Outcome Measures

12. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes

13. Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

14. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases -Meeting Report (Part 1)

15. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA

16. Does Rhinitis Pharmacotherapy Improve Control of Comorbid Asthma?

18. ARIA���EAACI statement on asthma and COVID���19 (June 2, 2020)

19. Pregnancy Outcomes of Patients with Asthma under Omalizumab Treatment: Case Report of a Country based Experience on 22 Pregnancies and 23 Infants

20. The Global Alliance against Chronic Respiratory Diseases: journey so far and way ahead

21. A global respiratory perspective on the COVID-19 pandemic: Commentary and action proposals

22. Does asthma control as assessed by the asthma control test reflect airway inflammation?

23. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

24. Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial

25. Sinusitis and Chronic Progressive Exercise-Induced Cough and Dyspnea

26. Helsinki by nature: The Nature Step to Respiratory Health

27. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy' AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) \nPOLLAR (Impact of Air POLLution on Asthma and Rhinitis)\nGARD Demonstration project

28. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

29. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

30. Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases

31. 2019 ARIA Care pathways for allergen immunotherapy

32. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

33. Asthma in the context of global alliance against respiratory diseases (GARD) in Turkey

34. A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD-common chronic respiratory diseases in global alliance against chronic respiratory diseases (GARD) countries

35. Are elderly and aged asthma different diseases? Results of a multicenter study

36. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS

37. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

38. Asthma phenotypes in Turkey: a multicenter cross-sectional study in adult asthmatics; PHENOTURK study

39. The 'physician on call patient engagement trial' (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients

40. Attention to ACOS in patients with asthma and COPD:Results from a national- multicentered study

41. Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma

42. Assessing the knowledge in primary health care following an educational course structured in the context of GARD chronic airway diseases national control program

43. Determination of Physical Activity and Dietary Attitudes in Asthma Patients and Evaluation of Their Relationship with Asthma Control: A National Multicenter Study

44. GINA 2019: a fundamental change in asthma management

45. Addressing patient-specific treatment needs in asthma management

46. Long acting beta-2 agonists in the treatment of asthma and their safety

47. Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper

48. Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

49. ARIA Update 2008: die allergische Rhinitis und ihr Einfluss auf das Asthma

50. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Catalog

Books, media, physical & digital resources